Hims & Hers Enters Australia with $6.5B Goal
The US healthcare company has rebranded the Pilot platform as part of its acquisition of Eucalyptus, aiming to introduce various healthcare services and replicate its US and European model in the Australian market
Hims & Hers has marked its entry into the Australian market, its first expansion into the Asia-Pacific region, with the rebranding of the Pilot platform. The company acquired Australian digital-health platform Eucalyptus, which includes men's health brand Pilot and women's health brand Juniper, as part of its growth strategy.
The initial rollout of services in Australia includes weight-loss and men's health treatments, with plans to introduce women's health services later this year. Hims & Hers also plans to provide access to branded GLP-1 medicines in Australia, including drugs such as Wegovy and Zepbound.
The company aims to increase customer acquisition and spending per subscriber by introducing multiple healthcare categories in Australia. This strategy has already shown promise, with international expansion helping to increase monthly revenue per subscriber by 21% year over year.
## What's at Stake Hims & Hers has set a long-term revenue target of $6.5 billion for 2030, and its expansion into Australia is a key part of this goal. The company's ability to replicate its US and European model in the Australian market will be crucial to its success. By leveraging local infrastructure and clinical expertise, Hims & Hers can reduce the risks associated with entering a new market and establish a strong presence in the region.
The Australian market offers a significant opportunity for Hims & Hers to increase its customer base and revenue. With its established local presence, existing brands, and clinicians, the company is well-positioned to introduce multiple healthcare categories and increase customer lifetime value. As Hims & Hers continues to expand its services in Australia, it will be important to monitor the company's progress and its impact on the local healthcare market.
## What Happens Next Hims & Hers has already launched weight-loss drugs in Australia, and the company plans to introduce additional services in the coming months. As the company continues to expand its presence in the Australian market, it will be important to watch for updates on its progress and its impact on the local healthcare industry. With its strong growth strategy and established local presence, Hims & Hers is well-positioned to succeed in the Australian market and achieve its long-term revenue goals.
